Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum

The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology
L M AmbroseE J Van Bockstaele

Abstract

Previous studies have shown significant changes in dopamine and opioid receptors in the basal ganglia following administration of cocaine. Cocaine administration results in a significant increase in the number of opioid receptors in dopamine-enriched brain regions. The aim of this study was to determine if dopamine D2 receptors (D2r) and micro-opioid receptors (microOr) are localized to the same neurons in the dorsolateral striatum. Immunoperoxidase and immunogold-silver labeling combined with electron microscopy was used to examine the ultrastructural localization of both receptors in the dorsolateral striatum. Approximately half of the microOr-labeled somatodendritic processes showed immunolabeling for the D2r. Similarly, about half of the D2r-labeled dendrites and cell bodies showed immunolabeling for the microOr. In conclusion, our results indicate that individual neurons in the rat dorsolateral striatum may be directly modulated by both dopaminergic and opioid ligands. These data also suggest that the molecular mechanism responsible for the up-regulation of microOrs in the caudate and putamen following cocaine exposure may depend, in part, on the co-existence of D2rs and micro-Ors in these cells.

References

Nov 1, 1992·Brain Research. Molecular Brain Research·Y L Hurd, M Herkenham
Jan 1, 1992·Canadian Journal of Physiology and Pharmacology·R A Swanson
Jun 28, 1992·Annals of the New York Academy of Sciences·K A CunninghamN E Goeders
Jul 3, 1992·Brain Research·E M UnterwaldM J Kreek
Mar 1, 1992·Brain Research. Molecular Brain Research·Y L HurdC R Gerfen
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·R A Frank, E Zubrycki
Oct 1, 1988·Pharmacology, Biochemistry, and Behavior·L C Nicolaysen, J B Justice
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·F TangJ P Schwartz
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L StinusM Le Moal
Apr 1, 1995·Brain Research. Molecular Brain Research·J B Daunais, J F McGinty
Jan 1, 1995·Brain Research Bulletin·J B DaunaisJ F McGinty
Aug 1, 1995·Pharmacology, Biochemistry, and Behavior·S R Tella
Nov 1, 1993·Brain Research. Molecular Brain Research·T E HeltonJ F McGinty
Dec 1, 1995·Trends in Neurosciences·Y KawaguchiP C Emson
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·I SoraG R Uhl
Apr 9, 1999·Nature Neuroscience·B A RochaM G Caron
Sep 15, 1999·Psychopharmacology·L T Tran-NguyenJ L Neisewander
Sep 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S P LeeS R George
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·I SoraG R Uhl
Dec 12, 2001·Neuroscience·E J Van Bockstaele, K G Commons
May 10, 2002·Hippocampus·Carrie T Drake, Teresa A Milner

❮ Previous
Next ❯

Citations

Aug 10, 2007·Psychopharmacology·Joseph A SchroederEllen M Unterwald
Jan 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dezhi LiaoHorace H Loh
Jul 14, 2011·Behavioural Pharmacology·Cynthia M GoochPeter D Balsam
May 1, 2009·Expert Opinion on Drug Discovery·Erin Cummins, Francesco Leri
Feb 6, 2015·Brain Structure & Function·Violeta G Lopez-HuertaGordon Arbuthnott
Jul 13, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Francesco LeriMary Jeanne Kreek
Aug 12, 2015·NeuroImage·Lauri TuominenLauri Nummenmaa
Jul 26, 2005·Peptides·Richard J Bodnar, Gad E Klein
Sep 22, 2006·The European Journal of Neuroscience·Constantinos D PaspalasPatricia S Goldman-Rakic
May 20, 2015·British Journal of Pharmacology·Florence NobleNicolas Marie
Sep 4, 2007·Neuroscience and Behavioral Physiology·M A Cheido, G V Idova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.